Stock listing

T3X Stock Price, News, Filings & Events — Telix Pharmaceuticals Limited

Selected listing: T3X · GETTEX · EUR · DE

The T3X:GETTEX listing represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on the development of targeted therapies for cancer. The company is engaged in advancing its pipeline of innovative products, with recent news highlighting progress in clinical trials and regulatory filings. Investors can find updates on upcoming events and market developments that may impact Telix's operations and growth potential. The page provides essential information for those interested in the company's strategic direction and market performance.

T3X:GETTEXEURDEUpdated July 21, 2026
Telix Pharmaceuticals Limited logo
Ticker
T3X:GETTEX
Asset type
Stock
Market cap
$3.71B
Sector
Health Technology
Industry
Biotechnology
Exchange
GETTEX
Currency
EUR

Telix Pharmaceuticals Limited T3X:GETTEX stock context

The T3X:GETTEX listing represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on the development of targeted therapies for cancer. The company is engaged in advancing its pipeline of innovative products, with recent news highlighting progress in clinical trials and regulatory filings. Investors can find updates on upcoming events and market developments that may impact Telix's operations and growth potential. The page provides essential information for those interested in the company's strategic direction and market performance.

Research Telix Pharmaceuticals Limited

Alternate listings